Literature DB >> 34559904

Cause-specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001-2017.

Graça M Dores1,2, Rochelle E Curtis1, Martha S Linet1, Lindsay M Morton1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34559904      PMCID： PMC8616843          DOI： 10.1002/ajh.26362

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   13.265


× No keyword cloud information.
  6 in total

Review 1.  Pulmonary toxicity of antineoplastic therapy.

Authors:  H Kreisman; N Wolkove
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

2.  Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients.

Authors:  Anna Ravn Landtblom; Therese M-L Andersson; Paul W Dickman; Karin E Smedby; Sandra Eloranta; Nurgul Batyrbekova; Jan Samuelsson; Magnus Björkholm; Malin Hultcrantz
Journal:  Leukemia       Date:  2020-06-16       Impact factor: 11.528

Review 3.  Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.

Authors:  Alison R Moliterno; Yelena Z Ginzburg; Ronald Hoffman
Journal:  Blood       Date:  2021-03-04       Impact factor: 22.113

4.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

Review 5.  Clonal hematopoiesis and nonhematologic disorders.

Authors:  Siddhartha Jaiswal
Journal:  Blood       Date:  2020-10-01       Impact factor: 25.476

6.  Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study.

Authors:  Kasper Mønsted Pedersen; Yunus Çolak; Hans Carl Hasselbalch; Christina Ellervik; Børge Grønne Nordestgaard; Stig Egil Bojesen
Journal:  EClinicalMedicine       Date:  2020-04-06
  6 in total
  1 in total

Review 1.  Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.

Authors:  Barbara Mora; Francesco Passamonti
Journal:  Curr Hematol Malig Rep       Date:  2022-09-01       Impact factor: 4.213
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.